EyePoint Pharmaceuticals, Inc. Collaboration Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Commercial Alliance Agreement between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC (Expansion of Imprimis Responsibilities)
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2022
Amendment One to Commercial Alliance Agreement between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2021
Commercial Alliance Agreement between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC (August 1, 2020)
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Amendment and Termination Agreement to Collaborative Research and License Agreement between PSIVIDA and PFIZER
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2017
Second Amended and Restated Collaboration Agreement between pSivida US, Inc. and Alimera Sciences, Inc. (July 10, 2017)
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
Amended and Restated Collaboration Agreement between pSivida, Inc. and Alimera Sciences, Inc. (March 14, 2008)
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2010
Amended and Restated Collaboration Agreement between pSivida Inc. and Alimera Sciences, Inc. (March 14, 2008)
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2008